| Literature DB >> 7705422 |
K Rudolf1, W Eberlein, W Engel, H A Wieland, K D Willim, M Entzeroth, W Wienen, A G Beck-Sickinger, H N Doods.
Abstract
The design and subsequent in vitro and in vivo biological characterisation of the first potent and selective non-peptide neuropeptide Y Y1 receptor antagonist, BIBP3226 ((R)-N2-(diphenylacetyl)-N-[(4-hydroxyphenyl)methyl]-argininami de) is reported. BIBP3226 displaced 125I-labelled neuropeptide Y with high affinity (Ki = 7 nM) from the human neuropeptide Y Y1 receptor and proved to be highly selective. BIBP3226 displayed potent antagonistic properties both in in vitro and in vivo models and thus represents the first selective non-peptide neuropeptide Y Y1 receptor antagonist.Entities:
Mesh:
Substances:
Year: 1994 PMID: 7705422 DOI: 10.1016/0014-2999(94)90822-2
Source DB: PubMed Journal: Eur J Pharmacol ISSN: 0014-2999 Impact factor: 4.432